Premium Bard PowerPort Mass Tort Case Leads & Signed Retainer Services

A Bard PowerPort is a medical device designed to help patients get long-term treatment with fewer needle sticks. This “Totally Implantable Venous Access Device” (TIVAD) should be a safe tool for chemotherapy and chronic care. However, design flaws have made these ports hazardous for many patients. When the catheter breaks or the material wears down, it often leads to life-threatening issues like sepsis, blood clots, and organ damage.

At Exclusive Leads Agency (ELA), we identify people with high intent and documented injuries. Our JD-led vetting process ensures your firm only receives claimants with documented fractures, sepsis, and confirmed device IDs. We confirm the device brand, the injury, and the medical treatment and deliver files ready for your team to review.

Get Qualified Leads Sent to You

Service Feature

ELA Standards

Exclusivity

100% Exclusive: Your cases are never sold to anyone else.

Verification

Every lead is checked for brand-name proof and medical records.

Compliance

Full TCPA and HIPAA compliance with TrustedForm records.

Medical Proof

We confirm visits to the ER, surgeries, or ICU stays.

Specialized Bard PowerPort Lead Generation for Medical Device Litigation

Do you know why generating leads for Bard PowerPort lawsuits is challenging? Because many patients do not know the brand of their port. Our team solves these issues by helping claimants review their medical history to find evidence of a Bard-branded device.

This litigation focuses on the materials used to make the port. Claims suggest that high levels of barium sulfate make the catheter brittle, leading to fractures and thrombosis. We focus on identifying individuals whose medical care was harmed by these preventable failures.

Specialized Bard PowerPort Lead Generation

Bard PowerPort Case Qualification Criteria

We use strict benchmarks to ensure every case meets litigation standards. Our screening process focuses on the following criteria

TIVAD Implantation Requirements

A qualifying case must involve a Bard PowerPort or a similar device manufactured by Bard or Becton, Dickinson and Company (BD).

  • Qualifying Models: PowerPort, ClearVue, Slim, MRI, Groshong, and Hickman.
  • Use Case: The port must have been used for chemotherapy or IV medication.
  • Exclusion: We disqualify ports used solely for dialysis.
  • Records: For implants prior to 2008, we review records to ensure the case is viable.
Law Firm

Qualifying Complications and Injuries

We categorize injuries to help your firm prioritize cases with the strongest evidence.

  • Mechanical Failures: Catheter fractures, cracks, breaks, device migration, or embolization (fragments traveling to the heart or lungs).
  • Infections (60-Day Window): Sepsis, bloodstream infections, septic shock, or necrosis occurring within 60 days of implantation.
  • Blood Clots: Confirmed Deep Vein Thrombosis (DVT), pulmonary embolisms, or catheter-related thrombosis.
  • Internal Injuries: Perforation of organs or vessels, cardiac tamponade, or strokes caused by device failure.

Medical Intervention & Removal

A lead only qualifies if they sought professional medical treatment. We verify:

  • Emergency Care: ER visits or ICU admissions for sudden complications.
  • Surgery: Procedures to remove the port (explantation) or retrieve broken pieces.
  • Therapy: Ongoing antibiotic treatment for sepsis or blood thinners for clots.
  • Removal Status: Indicates whether the device was removed due to failure or if removal is currently planned.
law firm
Mortgage Leads

Device Removal Requirement

Most successful claims involve a port that has been removed or is scheduled for removal due to a failure. We ask specific questions to find out:

  • If the port was removed due to any complication.
  • We analyze the timeline between the injury and the device removal to ensure the claim is viable
  • We distinguish between emergency explantations and planned removals to help you categorize case urgency.

Note: Some patients may still have the device if their medical treatment is still active.

Documentation and Evidence Requirements

Strong evidence is essential for filing. We help identify:

  • Medical Proof
  • Device ID
  • Physical Evidence
Timeline and Documentation Standards

Our 5-Step C.L.A.I.M. Validation Process

Every Bard PowerPort lawsuit mass tort case lead goes through our C.L.A.I.M. process to ensure it meets litigation standards.

C – Compliance & Consent

We get written consent and a TrustedForm certificate for every lead to ensure TCPA Compliance.

L – Legal Identity

Multi-factor checks verify the person’s identity and contact info to stop fraud.

A – Authentic Injury Proof

Our specialists review medical records to confirm a doctor’s diagnosis.

I – Injury Cross-Check

We match the date the port was used with the injury date to help show that the device caused the harm.

M – Medical Documentation

We find the exact hospital and doctor so your team can pull records fast.

Validation Process for Oxbryta Leads
Our Approach to Mass Tort Intelligence

Why Law Firms Choose Us for Bard PowerPort Leads

Attorneys trust us because our team understands Bard PowerPort leads from the inside out. We screen for:

  • Smart Screening: Checking for 60-day infections reduces the risk of filing weak cases.
  • Strategic Outreach: We treat cancer survivors with the empathy they deserve during every call.
  • Custom Plans: Campaigns are set to target specific injuries, such as fractures or sepsis cases.

Our Bard PowerPort Lead Generation & Delivery Process

With our strategic approach, we connect you with people who used these devices during chemotherapy or long-term medical care to identify those who suffered preventable injuries.

Targeted Outreach to TIVAD Users

We use targeted marketing strategies to reach oncology and chronic illness communities. 

  • We concentrate our outreach efforts on cancer survivors and current patients who have received chemotherapy through a port.
  • We also target patients with chronic illnesses who require long-term IV medication or nutrition.
  • We engage with oncology support communities and patient advocacy groups to identify claimants.
  • People are actively seeking assistance for port-related complications such as fractures or sepsis.

Comprehensive Lead Profiles

When we deliver a lead, we provide complete information. Every profile includes:

  • Implantation History: Detailed dates for when the device was put in and taken out.
  • Device Identification: The specific brand and model confirmed through medical notes.
  • Medical Background: Specify the reason for the port, including the specific type of cancer or treatment.
  • Complication Details: Precise timing of infections, blood clots, or mechanical failures.
  • Intervention Records: Information on ER visits, surgeries, and hospital stays.
  • Evidence Assessment: An audit of available documents, like Port ID cards or surgical reports.

Understanding the Device Defect: Barium Sulfate

The Bard PowerPort is intended to remain in the body throughout a patient’s treatment. Bard incorporated barium sulfate into the plastic catheter to ensure it is visible on X-rays.

While it makes the device visible on X-rays, it compromises the plastic’s integrity, creating microscopic cracks that trap bacteria and cause sepsis. These cracks also weaken the catheter, causing it to snap and float into the heart or lungs.

Current Bard PowerPort Litigation Status and MDL

Thousands of cases are currently moving through MDL 3081 in Arizona. The court has scheduled several “bellwether” trials to begin this year. The legal arguments in these initial proceedings will focus on serious infections and mechanical failures of catheters. These early outcomes often serve as a roadmap for a future global settlement. Law firms should secure their case inventory before the established filing deadlines pass.

Settlement Potential for Bard PowerPort Cases

While every claim is unique, legal experts often examine similar medical device lawsuits to estimate potential settlement ranges.

Potential Settlement Tiers

  • High-Value Cases: Catastrophic outcomes often fall into this category, including deaths from septic shock, pulmonary embolisms, or cardiac tamponade. 
  • Mid-Value Cases: Serious injuries that required intensive treatment but ended in recovery generally sit in this tier, such as sepsis requiring hospitalization, pulmonary embolisms, and catheter fractures.
  • Lower-Tier Cases: Recoverable complications typically involve infections that resolve with antibiotics and device removal.
Business
Rideshare Assault Lead Generation & Delivery Process

Factors That Influence Case Value

Several variables determine where a case might fall within these tiers. The severity of the complication and how long someone has to stay in the hospital or ICU are two important factors. 

Other Key Valuation Factors:

  • Complication Severity: ER visits vs. extended ICU stays.
  • Treatment Interruption: Impact of device failure on ongoing oncology care.
  • Economic Damages: Lost wages, medical expenses, and permanent disability.
  • Demographics: Age of the patient at the time of injury.

Disclaimer: Settlement values vary significantly. These estimates are based on outcomes from similar medical device cases and are not a guarantee of results. Individual case facts will ultimately control the outcome of any claim.

The Litigation Opportunity for Law Firms

With over 2,600 active cases in MDL 3081, the Bard PowerPort litigation is growing rapidly. Scientific evidence links barium sulfate degradation to severe patient injuries and provides a solid foundation for design defect claims.

By securing high-quality cases now, your firm can build a strong inventory before bellwether trials set the stage for a global settlement. 

At Exclusive Leads Agency, we provide the “litigation-ready” claimants you need to scale your practice efficiently without wasting time on unverified data.

Competitive Advantages in Oxbryta

Contact Us for Exclusive Bard PowerPort Leads

Get Bard PowerPort legal leads that are verified, exclusive, and ready for your team to work on right away. Contact Exclusive Leads Agency today to see if your target states are still open.

Frequently Asked Questions

We follow a "One Case, One Firm" rule. We never sell the same lead to different firms. Every lead also comes with proof of a Bard device.

Strong cases usually show an infection within 60 days of the implant. This helps prove the device itself caused the infection.

If a lead does not meet the standards we agreed on, we replace it at no extra cost to you.

We offer a "Signed Retainer" model in which we handle intake and deliver a client who has already signed your firm's contract.

Our team uses surgical records and hospital notes to confirm the exact model and maker of the port.